Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA)

Tekgunduz E., Arat M., GÖKER H., Ozdogu H., KAYNAR L., Cagirgan S., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.56, sa.6, ss.845-849, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56 Sayı: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.transci.2017.11.025
  • Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.845-849
  • Anahtar Kelimeler: Autologous hematopoietic cell, transplantation, Lymphoma, Myeloma, Mobilization, COLONY-STIMULATING FACTOR, BIOSIMILAR FILGRASTIM LEUCOSTIM(R), PLUS G-CSF, MARROW TRANSPLANTATION, ORIGINATOR FILGRASTIM, AMERICAN SOCIETY, WORKING GROUP, LENOGRASTIM GRANOCYTE(R), POOR MOBILIZATION, COST-ANALYSIS
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Autologous hematopoietic cell transplantation (AHCT) is a routinely used procedure in the treatment of adult patients presenting with multiple myeloma (MM), Hodgkin lymphoma (HL) and various subtypes of non-Hodgkin lymphoma (NHL) in upfront and relapsed/refractory settings. Successful hematopoietic progenitor cell mobilization (HPCM) and collection are the rate limiting first steps for application of AHCT. In 2015, alinost 1700 AHCT procedures have been performed for MM, HL and NHL in Turkey. Although there are recently published consensus guidelines addressing critical issues regarding autologous HPCM, there is a tremendous heterogeneity in terms of mobilization strategies of transplant centers across the world. In order to pave the way to a more standardized HPCM approach in Turkey, Turkish Society of Apheresis (TSA) assembled a working group consisting of experts in the field. Here we report the position statement of TSA regarding autologous HPCM mobilization strategies in adult patients presenting with MM and lymphoma. (C) 2017 Elsevier Ltd. All rights reserved.